Autologous Cell Therapy Market Outlook; Up-to-date Development Data and Industry Trends Forecast from 2017-2021
Jun 14, 2017
Research analysts forecast the global autologous cell therapy market to grow at a CAGR of 23.39% during the period 2017-2021.
Dallas, United States - June 14, 2017 /MarketersMedia/ —
Autologous cell therapy belongs to the field of regenerative medicine and is based on biologic cell-based therapies to cure various diseases, including those of oncology, neurology, and dermatology, to name a few. Autologous cell therapy is one of the fastest growing segments of regenerative medicine and hence, is attracting significant research funds from various quarters.
Request additional details of this report at Orbis Research
The report covers the present scenario and the growth prospects of the global autologous cell therapy market for 2017-2021. To calculate the market size, the report considers the sales of autologous stem cell as well non-stem cell products.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Research report, Global Autologous Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Read more details of the report at: http://www.orbisresearch.com/reports/index/global-autologous-cell-therapy-market-2017-2021
Key vendors
• Brainstorm Cell Therapeutics
• Holostem Advanced Therapies
• Osiris Therapeutics
• Valeant
• Vericel Corporation
Other prominent vendors
• AbbVie
• American CryoStem
• AM-Pharma
• Anterogen
• apceth Biopharma
• Astellas Pharma
• Athersys
• Baxter International
• Beike Biotechnology
• BIOTIME
• bluebird bio
• Bristol-Myers Squibb
• Brainxell
• Caladrius Biosciences
• Cellular Biomedicine Group
• Cellular Dynamics International (a subsidiary of Fujifilm)
• Cesca Therapeutics
• CHA Biotech
• Chugai Pharmaceutical
• Citospin
• Corestem
• Cytori Therapeutics
• Daiichi Sankyo
• Fujifilm
• Gamida Cell
• Global Stem Cells Group
• Grupo Ferrer Internacional
• GlaxoSmithKline
• Hemostemix
• Histocell
• International Stem Cell
• Ivy Institute of Stem Cells
• Japan Regenerative Medicine
• Kangstem Biotech
• Kiadis Pharma
• Laboratorios Salvat
• MEDIPOST
• Mesoblast
• Nuo Therapeutics
• Opsis Therapeutics
• Pharmicell
• Pluristem Therapeutics
• Promethera Biosciences
• Q Therapeutics
• ReNeuron
• RHEACELL
• Salus Medical Solutions
• Sangamo Therapeutics
• Shire
• Steminent Biotherapeutics
• Sumitomo Dainippon Pharma
• Taiwan Bio Therapeutics
• Takeda Pharmaceutical
• Teva Pharmaceutical Industries
• Thoratec Corporation
• TiGenix
• Translational Biosciences
• TWO CELLS
• U.S. Stem Cell
• ViaCyte
• VistaGen Therapeutics
Market driver
• Increasing demand for effective drugs for cardiac and degenerative disorders
• For a full, detailed list, view our report
Market challenge
• Critical ethical challenges with respect to stem cell research
• For a full, detailed list, view our report
Market trend
• Private funding will fuel market growth
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Enquire more details of the report at: http://www.orbisresearch.com/contact/purchase/319422
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Info:
Name: Hector Costello
Email: [email protected]
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A.
Phone: +1 (214) 884-6817
For more information, please visit http://www.orbisresearch.com/reports/index/global-autologous-cell-therapy-market-2017-2021
Source: MarketersMedia
Release ID: 207810
More News
Charity reflects on changing needs over 25 years
Help a Guernsey Child says it has provided in excess of £1.2m worth of essential support.
Nightclubs are disappearing - and it's affecting young people
One young person said with no nightlife in their town they cannot "let loose and mess around".
M.L.B. Playoff Ads With Sydney Sweeney and Megan Fox Draw Backlash
Commercials with Sydney Sweeney promoting a gambling platform and Megan Fox endorsing male enhancement have rankled fans, and even athletes. Who is in charge?
Netflix Hurries to Rewrite Its Narrative With Layoffs and a Sudden Firing
Despite strong revenues and profits, the streaming service cut 1,000 jobs and jettisoned its chief content officer. Drops in the stock price and viewer engagement are to blame.
Why Bad News in the Bond Market May Be Good News for Investors
In the contrarian logic of investing, rising interest rates have made bonds much more attractive, our columnist says.
U.S. Budget Deficit Nears $2 Trillion, a Reality Check for Trump’s Cost Cutting
Higher interest rates are inflating borrowing costs as the Trump administration spends on the Iran war and tariff refunds.
Indonesian Stocks Plunge as MSCI Threatens to Drop Market from Indexes
The potential downgrade by MSCI, an influential index provider, adds to a deepening crisis of investor confidence in the economic policies of President Prabowo Subianto.
Warsh Vows to Tame Inflation as A.I. Delivers ‘Shock’ to Economy
The Federal Reserve chairman stuck to his pledge to avoid providing guidance about the path forward for interest rates, but did nothing to convey an urgency to raise them later this month.
A new railway corridor: How Nanning links Chinese and ASEAN markets
A new railway corridor: How Nanning links Chinese and ASEAN markets
Watch: Did Tesla really just unveil a flying car?
Tesla CEO Elon Musk showcased the vehicle at a facility owned by his SpaceX company, which helped develop the model.
China and Europe are building new connections in aerospace
China and Europe are building new connections in aerospace – from skies to stars. On the one hand, their deep industrial partnership is scaling global civil aviation to new heights. On the other hand, scientific collaboration is opening new possibilities for space exploration and deepening our understanding of the Sun-Earth system.
BizTalk | Exclusive interview with Former PM of Bosnia and Herzegovina
In this episode of BizTalk, CGTN's Guan Xin speaks with Zlatko Lagumdzija, former prime minister of Bosnia and Herzegovina, about China's development and its role in global governance.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.